Samjin Pharmaceutical Magok Research Center Wins Excellence Award at the 2022 Korea Architecture Culture Awards
[Asia Economy Reporter Lee Gwan-ju] Samjin Pharmaceutical announced on the 28th that its Magok Research Center won the Excellence Award in the Private Sector for Buildings at the '2022 Korea Architecture Culture Awards.'
The Korea Architecture Culture Awards is the most prestigious event in the field of architecture hosted by the Ministry of Land, Infrastructure and Transport. This year, a total of 17 buildings were selected as awardees in the building category.
Samjin Pharmaceutical's Research Center received the Excellence Award in the private sector for its user-friendly design and space planning, as well as being an eco-friendly building. Previously, it also won three awards in the 'Seoul Metropolitan Government Architecture Awards,' including the Completion Division (Excellence Award), Green Architecture Award, and Citizen Sympathy Special Award.
Hot Picks Today
"You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Mistaken for the Flu, Left Untreated... Death Toll Surges as WHO Declares Emergency (Comprehensive)
- Jinwoo Sunim: "We Must Abandon the Extremes of Surviving by Defeating Others"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Opened in December last year in Magok-dong, Gangseo-gu, Seoul, the Samjin Pharmaceutical Research Center is a building with a total floor area of 13,340㎡, consisting of four basement floors and eight above-ground floors. It is equipped with comfortable laboratories and state-of-the-art experimental equipment, enabling the entire process from early-stage new drug development to clinical trials and approval to be conducted independently.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.